Select Page
Responsive Centered YouTube Video
Discovery of SARS-COV2 replicating in bacteria raises questions about virus behavior.
  • Dr. Carlo Brognia’s research on SARS-COV2 replication in fecal matter and bacteria. 0:11

  • Peer-reviewed study showing increase in viral load prompts rethinking of virus biology. 1:27

  • Experiment mixing fecal samples from COVID-19 positive and healthy individuals. 2:03

  • Importance of understanding active enterocytes in virus infection. 3:01

  • Illustration of bacteriophage infecting bacteria, highlighting virus behavior. 3:33

SARS-CoV-2 virus can replicate in bacteria and its growth in fecal matter can be impacted by certain antibiotics.
  • Bacteriophages play a role in how bacteria spread resistance to antibiotics. 4:41

  • Mixing SARS-CoV-2 virus with healthy bacteria showed increased viral RNA load in fecal matter. 6:03

  • Certain antibiotics like metronidazole, vancomycin, and amoxicillin had an impact on the growth of the virus. 6:57

  • Using antibiotics can reduce or stop the viral RNA load in feces by killing bacteria. 7:40

  • Detection of SARS-CoV-2 in human fecal matter raises concerns and requires further investigation. 8:05

Discovery of unique viral activity raises questions about virus origins and transmission.
  • Unprecedented viral activity observed within and outside bacteria. 8:22

  • Importance of investigating virus evolution and natural origins. 8:44

  • Possibility of fecal-oral transmission and long-term symptoms. 9:20

  • Research revealing potential replication cycle of the virus. 10:06

  • Ongoing journey to fully understand COVID-19 disease. 10:46